Page last updated: 2024-09-04

lonafarnib and Tauopathies

lonafarnib has been researched along with Tauopathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boctor, D; Cerovac, V; Cuervo, AM; Diaz, A; Fisher, SK; Giroux, M; Goate, AM; Guzman, E; Haggarty, SJ; Hernandez, I; Hinman, CR; Kang, AA; Karch, CM; Kaushik, S; Kosik, KS; Luna, G; Rauch, JN; Reis, SA; Sibih, YE; Storm, NJ; Zekanowski, C; Zhou, H	1

Other Studies

1 other study(ies) available for lonafarnib and Tauopathies

Article	Year
A farnesyltransferase inhibitor activates lysosomes and reduces tau pathology in mice with tauopathy. Science translational medicine, 2019, 03-27, Volume: 11, Issue:485 Topics: Animals; Brain; Disease Models, Animal; Enzyme Inhibitors; Farnesyltranstransferase; Female; GTP-Binding Proteins; Humans; Induced Pluripotent Stem Cells; Lysosomes; Male; Mice; Mice, Transgenic; Mutation; Neurons; Piperidines; Proteolysis; Pyridines; RNA, Small Interfering; tau Proteins; Tauopathies; Translational Research, Biomedical	2019

Article

Year

A farnesyltransferase inhibitor activates lysosomes and reduces tau pathology in mice with tauopathy.

Science translational medicine, 2019, 03-27, Volume: 11, Issue:485

Topics: Animals; Brain; Disease Models, Animal; Enzyme Inhibitors; Farnesyltranstransferase; Female; GTP-Binding Proteins; Humans; Induced Pluripotent Stem Cells; Lysosomes; Male; Mice; Mice, Transgenic; Mutation; Neurons; Piperidines; Proteolysis; Pyridines; RNA, Small Interfering; tau Proteins; Tauopathies; Translational Research, Biomedical

2019